ZEON MEDICAL
MAIN MENU
Topic
Company
Contact Us
Privacy Policy
Disclaimer
Download
(Members only)
Home
English Japanese
Home Company Corporate Profile
Philosophy Message From the President Corporate Profile Research and development ZEON Group
Corporate Profile
Founded May 1, 1989
Capital 452 million yen (as of March 2019)
Sales 5,143 million yen (for fiscal year 2018)
Shareholder ZEON CORPORATION
(listed in the first section of the Tokyo Stock Exchange) (100%)
http://www.zeon.co.jp/
Employees 206 (as of March 2019)
Head Office 1-6-2 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan
TEL: +81-3-3216-1266
FAX: +81-3-3216-1270
Domestic
Network
Plant and R&D Center: Takaoka, Toyama prefecture
Sales Branches: Sapporo, Sendai, Nagoya, Osaka, Hokuriku, Hiroshima and Fukuoka
Products Medical devices for cardiac/circulatory, digestive and intravenous nutrition systems, and other devices.
Our original brand "XEMEX"represents ZEON MEDICAL EXCELLENCE.
“Z” standing for ZEON was replaced with “X”, indicating “challenging to unknown fields” and enclosing our sense of active pursuit in the field of medical devices.
History
ZEON MEDICAL launched operations on January 1, 1990 as an affiliated company of ZEON CORPORATION , a polymer chemistry manufacturer. ZEON CORPORATION has continued to develop medical devices utilizing innovative materials, particularly biomaterials, produced by combining the company's exclusive technologies. The ventricular artificial heart, a typical medical device resulting from these efforts, was the first such product in the world to obtain approval for manufacture from the former Ministry of Health and Welfare (currently the Ministry of Health, Labor and Welfare) in January 1990.
ZEON MEDICAL INC. began operations in January of the same year to sell these products. In July 1996, the export, research and development and manufacturing operations of ZEON CORPORATION were transferred to ZEON MEDICAL, and ZEON MEDICAL completed the establishment of an integrated system as a highly respected and integrated medical device manufacturer. Since then, the Company has been committed to expanding this field of business.


1979-1981 The Research and Development Center of ZEON CORPORATION started commercial development of a ventricular artificial heart in response to a request from University of Tokyo.
1982-1989 Nine clinical studies and 61 clinical trials implemented, primarily by Nihon University, Tohoku University and Tokyo Women's Medical University.
May 1989 ZEON MEDICAL INC. founded as a domestic distribution company for medical devices of ZEON CORPORATION
December 1989 Manufacturing of the ventricular artificial heat approved by the Central Pharmaceutical Affairs Council of the Ministry of Health and Welfare.
January 1990 ZEON MEDICAL INC. launched operations.
May 1990 World's smallest external stationary pacemaker developed and marketed.
July 1996 Research, development, manufacturing and export operations of ZEON CORPORATION transferred to ZEON MEDICAL.
March 2002 Takaoka Medical Device Second Plant completed.
April 2004 ISO 13485 certification obtained.
May 2007 Research and development Center moved to Takaoka.

TOP
Copyright (c) ZEON MEDICAL INC.All rights Reserved.